Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for prevention of postoperative delirium after neurosurgery
IRCT20211211053353N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of melatonin in delirium (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Incidence of delirium. Started Jan 2022; status: completed.
02
Drugs
melatonin
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20211211053353N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211211053353N1.